Invention Grant
US08987311B2 Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
有权
可用作激酶抑制剂的三唑基取代的吡啶基化合物
- Patent Title: Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
- Patent Title (中): 可用作激酶抑制剂的三唑基取代的吡啶基化合物
-
Application No.: US14371281Application Date: 2013-01-11
-
Publication No.: US08987311B2Publication Date: 2015-03-24
- Inventor: Dharmpal S. Dodd , Christopher P. Mussari , Rajeev S. Bhide , Satheesh Kesavan Nair , Venkatram Reddy Paidi , Sreekantha Ratna Kumar , Abhisek Banerjee , Ramesh Sistla , William J. Pitts , John Hynes
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary D. Greenblatt
- International Application: PCT/US2013/021096 WO 20130111
- International Announcement: WO2013/106614 WO 20130718
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K31/44 ; C07D471/10 ; C07D417/14
Abstract:
Compounds having the following formula: (I) wherein: A is an optionally substituted triazole, or a stereoisomer or a pharmaceutically-acceptable salt thereof, are useful as kinase modulators, including IRAK-4 modulation.
Public/Granted literature
- US20150045347A1 TRIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2015-02-12
Information query
